TECregen, a Swiss biotech advancing thymus regeneration, has announced the successful completion of a 10 million Swiss francs ...

Independent French pharma major Servier today announced the creation of Servier Ventures, a fully owned corporate venture ...

UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...

The launch of USA-based Poplar Therapeutics has been announced, alongside a $50 million Series A financing led by SR One, ...

Swiss biotech TECregen has raised 10 million Swiss francs ($12.6 million) in seed financing to advance its thymus ...

European private equity company Andera Partners today announced that it is co-leading a $159.8 million Series A round of ...

Swiss specialty drugmaker Santhera Pharmaceuticals announces it has signed an exclusive licensing agreement with Nxera Pharma ...

Indian drugmaker Granules India (BSE: 532482) has announced its US subsidiary has secured tentative approval from the ...

Danish biotech Genmab (Nasdaq: GMAB) has partnered with artificial intelligence company Anthropic to deploy agentic AI tools ...

AstraZeneca’s new head of Investor Relations, Joris Silon, succeeds Andy Barnett on 1 March 2026, and will be based in ...

UK-based clinical-stage ophthalmic gene therapy biotech Beacon Therapeutics today announced that it has raised over $75 ...

Following rumors over the last couple of days, US pharma major Eli Lilly has confirmed that it plans to acquire Ventyx ...